Compound ID | 731
Class: Aminoglycoside
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Use against CAP and gastrointestinal infections. Spectinomycin analog with greater potency than its parent molecule |
| Description: | Novak, E., et al. "Safety and preliminary pharmacokinetics of intravenously administered trospectomycin sulfate (U-63,366 F) in man: a novel spectinomycin analogue [abstr 271]." 27th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). 1987. |
| Institute where first reported: | Pharmacia&Upjohn (Pfizer, US) |
| Year first mentioned: | 1984 |
| Highest developmental phase: | Phase 3 |
| Development status: | Inactive |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/55886 |
| Guide to Pharmacology: | trospectomycin |
| Citations: |
|